Kuldeep Rajput

Biofourmis, Inc. engages in the develop and deliver of clinically validated software-based therapeutics. It offers Biovitals which predicts clinical exacerbation in advance of a critical event. The company was founded by Kuldeep Singh Rajput and Wendou Niu in 2016 and is headquartered in Boston, MA.

Biofourmis, Inc. engages in the develop and deliver of clinically validated software-based therapeutics. It offers Biovitals which predicts clinical exacerbation in advance of a critical event. The company was founded by Kuldeep Singh Rajput and Wendou Niu in 2016 and is headquartered in Boston, MA.

Biofourmis, Inc. engages in the develop and deliver of clinically validated software-based therapeutics. It offers Biovitals which predicts clinical exacerbation in advance of a critical event. The company was founded by Kuldeep Singh Rajput and Wendou Niu in 2016 and is headquartered in Boston, MA.

Biofourmis Singapore Pte Ltd. engages in the development and delivery of clinically validated software-based therapeutics products. It focuses on robust digital therapeutics products and pipeline which covers multiple therapeutic areas including heart failure, acute coronary syndrome, COPD, and chronic pain. It offers solutions for healthcare systems, pharmaceuticals, prayers, and healthcare providers. The company was founded in 2015 by Kuldeep Singh Rajput and Wendou Niu and is headquartered in Singapore.

Biofourmis Singapore Pte Ltd. engages in the development and delivery of clinically validated software-based therapeutics products. It focuses on robust digital therapeutics products and pipeline which covers multiple therapeutic areas including heart failure, acute coronary syndrome, COPD, and chronic pain. It offers solutions for healthcare systems, pharmaceuticals, prayers, and healthcare providers. The company was founded in 2015 by Kuldeep Singh Rajput and Wendou Niu and is headquartered in Singapore.

Biofourmis Singapore Pte Ltd. engages in the development and delivery of clinically validated software-based therapeutics products. It focuses on robust digital therapeutics products and pipeline which covers multiple therapeutic areas including heart failure, acute coronary syndrome, COPD, and chronic pain. It offers solutions for healthcare systems, pharmaceuticals, prayers, and healthcare providers. The company was founded in 2015 by Kuldeep Singh Rajput and Wendou Niu and is headquartered in Singapore.

Biofourmis AG engages in the research in as well as the development and marketing of methods and devices for the collection of physiological and metabolic parameters in humans. It also acquires, manages, and disposes tangible and intangible assets. The company was founded on September 23, 2019 and is headquartered in Zurich, Switzerland.

Biofourmis AG engages in the research in as well as the development and marketing of methods and devices for the collection of physiological and metabolic parameters in humans. It also acquires, manages, and disposes tangible and intangible assets. The company was founded on September 23, 2019 and is headquartered in Zurich, Switzerland.

Biofourmis, Inc. engages in the develop and deliver of clinically validated software-based therapeutics. It offers Biovitals which predicts clinical exacerbation in advance of a critical event. The company was founded by Kuldeep Singh Rajput and Wendou Niu in 2016 and is headquartered in Boston, MA.